NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY

This article is dedicated to a monogenic polysystemic disease — mucoviscidosis; its course severity and prognosis are to a large extend determined by the degree of lung affection, infection and chronic inflammatory process development in the airways. The authors show the derangement of the quality o...

Full description

Saved in:
Bibliographic Details
Main Authors: V. V. Chernikov, S. A. Krasovskiy
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2012-10-01
Series:Педиатрическая фармакология
Subjects:
Online Access:https://www.pedpharma.ru/jour/article/view/294
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849404757774434304
author V. V. Chernikov
S. A. Krasovskiy
author_facet V. V. Chernikov
S. A. Krasovskiy
author_sort V. V. Chernikov
collection DOAJ
description This article is dedicated to a monogenic polysystemic disease — mucoviscidosis; its course severity and prognosis are to a large extend determined by the degree of lung affection, infection and chronic inflammatory process development in the airways. The authors show the derangement of the quality of life in children with mucoviscidosis and examine approaches to the therapy adherence issues, which is important for the treatment effectiveness. On the example of their own study and international experience they show the effectiveness of the inhalation technique of the drug delivery to a pathological nidus.
format Article
id doaj-art-78110d5b197e43ce96e55a4afd2d989c
institution Kabale University
issn 1727-5776
2500-3089
language Russian
publishDate 2012-10-01
publisher Union of pediatricians of Russia
record_format Article
series Педиатрическая фармакология
spelling doaj-art-78110d5b197e43ce96e55a4afd2d989c2025-08-20T03:36:53ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892012-10-0195869010.15690/pf.v9i5.461294NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPYV. V. Chernikov0S. A. Krasovskiy1Scientific Centre of Children’s Health, Moscow, Russian FederationResearch Institute of Pulmonology, Moscow, Russian FederationThis article is dedicated to a monogenic polysystemic disease — mucoviscidosis; its course severity and prognosis are to a large extend determined by the degree of lung affection, infection and chronic inflammatory process development in the airways. The authors show the derangement of the quality of life in children with mucoviscidosis and examine approaches to the therapy adherence issues, which is important for the treatment effectiveness. On the example of their own study and international experience they show the effectiveness of the inhalation technique of the drug delivery to a pathological nidus.https://www.pedpharma.ru/jour/article/view/294mucoviscidosisinheritancecoursetherapy adherenceantibacterial therapytobramycin dosage formschildren
spellingShingle V. V. Chernikov
S. A. Krasovskiy
NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY
Педиатрическая фармакология
mucoviscidosis
inheritance
course
therapy adherence
antibacterial therapy
tobramycin dosage forms
children
title NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY
title_full NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY
title_fullStr NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY
title_full_unstemmed NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY
title_short NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY
title_sort new step in the life quality improvement of patients with mucoviscidosis tobramycin for anapnotherapy
topic mucoviscidosis
inheritance
course
therapy adherence
antibacterial therapy
tobramycin dosage forms
children
url https://www.pedpharma.ru/jour/article/view/294
work_keys_str_mv AT vvchernikov newstepinthelifequalityimprovementofpatientswithmucoviscidosistobramycinforanapnotherapy
AT sakrasovskiy newstepinthelifequalityimprovementofpatientswithmucoviscidosistobramycinforanapnotherapy